Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Delaying therapy for HL/NHL likely safe for mom, baby

    Author:
    HT Staff
    Publish date: June 9, 2016

    A single-center retrospective study of 39 pregnant women diagnosed with Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL) during pregnancy...

    • Read More

    News

    Late sepsis death not explained by pre-existing conditions

    Author:
    HT Staff
    Publish date: June 8, 2016

    A new study sheds light on whether an increased risk of death in the 30 days to 2 years after contracting sepsis is caused by sepsis itself, or...

    • Read More

    News

    Hispanic, black AYA more likely to die of their cancer

    Author:
    HT Staff
    Publish date: June 7, 2016

    © ASCO/Zach Boyden-Holmes CHICAGO—Hispanic white and non-Hispanic black adolescents and young adults (AYA) are more likely to die of their...

    • Read More

    News

    EC broadens indication for ibrutinib

    Author:
    HT Staff
    Publish date: June 6, 2016

    The European Commission (EC) has broadened the indication for ibrutinib (Imbruvica) to include newly diagnosed patients with chronic lymphocytic...

    • Read More

    News

    Sodium influx may be key to killing Plasmodium parasites

    Author:
    HT Staff
    Publish date: June 6, 2016

    Two new anti-malaria drug candidates with different mechanisms of action—a pyrazoleamide and a spiroindolone—promote an influx of sodium ions into...

    • Read More

    News

    Women with AF less likely to get blood thinners

    Author:
    HT Staff
    Publish date: June 5, 2016

    Using an Atrial Fibrillation Decision Support Tool (AFDST), investigators determined that 45% of women and 39% of men in the study population were...

    • Read More

    News

    Ingredient in aspirin may help fight leukemia

    Author:
    HT Staff
    Publish date: June 4, 2016

    Photo credit: Jill Watson Researchers say they may have found a new use for an ancient anti-inflammatory drug, salicylate, which was first...

    • Read More

    News

    Young HCT survivors have increased risk for frailty

    Author:
    HT Staff
    Publish date: June 3, 2016

    Frailty among young adult hematopoietic cell transplant (HCT) survivors is high and approaches that of a community-based elderly population,...

    • Read More

    News

    Team develops new approach to programming T cells

    Author:
    HT Staff
    Publish date: June 3, 2016

    Using mouse models, researchers have developed a new cellular programming approach to create alloreactive T cells they say eliminate leukemic...

    • Read More

    News

    Platelet transfusions do not reduce IVH risk in VLBW infants

    Author:
    HT Staff
    Publish date: June 2, 2016

    A retrospective, multicenter study of 972 very-low-birth-weight (VLBW) infants treated in 6 US neonatal intensive care units (NICUs) has shown...

    • Read More

    News

    Two compounds show promise against Zika virus

    Author:
    HT Staff
    Publish date: June 2, 2016

    Two compounds have shown activity against the Zika virus, according to Biotech Biotron, a company that develops compounds to fight viral diseases...

    • Read More

    News

    Negative RT-PCR result doesn’t exclude Zika infection

    Author:
    HT Staff
    Publish date: June 1, 2016

    Photo by Jeremy L.

    • Read More

    News

    Blood test may aid diagnosis of HELLP

    Author:
    HT Staff
    Publish date: June 1, 2016

    A blood test developed to diagnose a rare genetic blood cell disorder, atypical hemolytic uremic syndrome (aHUS), may also aid in the diagnosis of...

    • Read More

    News

    AYAs still fare worse than kids with leukemia, lymphoma

    Author:
    HT Staff
    Publish date: May 31, 2016

    patient and her father Photo by Rhoda Baer Adolescents and young adults (AYAs) are less likely than children to survive 8 relatively common types...

    • Read More

    News

    CHMP advises against approving MM drug

    Author:
    HT Staff
    Publish date: May 30, 2016

    multiple myeloma The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has advised the European Commission not to...

    • Read More

    Pages

    • « first
    • …
    • 113
    • 114
    • 115
    • 116
    • 117
    • 118
    • 119
    • 120
    • 121
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery